Umeå based Omnio enters into a collaboration with Canadian ProMetic Life Science, to develop a "Biologics product", a drug, that speeds up the healing of otherwise very hard-to-treat wounds including diabetic foot ulcers. The collaboration includes research funding and funding for development and clinical studies of a drug based on the blood plasma protein plasminogen.
The day started with a string of pearls of interesting spin-offs, for the most part former Umeå Biotech Incubator and Uminova Innovation collaborators. So, what better way to crown the Umeågala than with especially inspiring and award-winning companies. MD Biomedical and Nordic Biomarker were honored as spin-off and export company of the year.
Proposals are invited from applicants affiliated with an SME. Call opens 22 Sept and closes 5 pm, 9 Nov 2015.
To save and improve patients’ lives, thousands of complicated surgeries are performed every year, but so far it has been difficult to monitor the status, how the organ is doing and working, after surgery. The Umeå based company MD Biomedical have developed a surveillance probe capable of measuring that. To facilitate the use of the probe within in the clinics, MD Biomedical have received 50 000 € to continue their work.
Can part of you company’s future be found in Japan? In conjunction with the Bio Japan Expo in October, Asias premier Partnering Event, EEN in collaboration with the EU- Japan centre, are organizing a five day trip to Japan with seminars, corporate visits, matchmaking and of course the Bio Japan Expo. It is also possible to apply for a stipend that cover some living expenses.
Umeå spin-off and medtech company MD Biomedical, with its innovative patient surveillance technique, is acquired as a subsidiary to Swedish Senzime.
Karo Bio acquires 100 percent of the drug research company Tanomed AB, for 20 MSEK. Through the acquisition, Karo Bio gains access to Tanomed’s unique nasal spray to relieve and prevent the progression of common cold; by reinforcing the body’s own defenses.
MyOroface, a Biotech Umeå and Uminova Innovation supported company, won 100 000 SEK and ALMI Invests pitch competition at Åre kapitalmarknadsdagar.
The spirits were high as the 17 local biotech companies, national and international investors, industrial partners, sponsors, and speakers had the chance to take the pulse of one another, during partnering and mingle in the gilt-edged surroundings of Grand Hôtel on January 27. This year’s investment event certainly served as a starting point for many interesting discussions.
The spin-off company, and former UBI project, Pro Test Diagnostics AB, have received a step wise investment from Fort Knox Förvaring, to ensure that Pro Test Diagnostics blood doping test reaches the market within three years. The goal is to be able to provide costumers like WADA (World Anti Doping Association) with a fool proof test that can expose blood doped athletes. Something that until now has been lacking.
Biotech, pharma, or medtech? Looking for investors, partners or other new business contacts?
Biotech Umeå Investement Day, February 4 2016, Grand Hôtel
Biotech Umeå, Uminova Innovation
Box 7978, SE-907 19 Umeå